SCHEMBL10044604

SCHEMBL10044604

CCc1cc(OC)cc(OC)c1CC

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
TAAR1 Q96RJ0 3/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP3A4 P08684 2/20 0.41
HSD17B10 Q99714 1/20 0.41
PTPN1 P18031 1/20 0.41
APLNR P35414 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
USP2 O75604 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5185794 0.87 ALDH1A1 (0.48) CYP1A2ALDH1A1CYP3A4PTPN1APLNR
SCHEMBL13067433 0.79 CYP1A2 (0.46) CYP1A2TAAR1ALDH1A1CYP3A4HSD17B10
SCHEMBL10044958 0.79 CYP1A2 (0.65) CYP1A2TAAR1ALDH1A1CYP3A4HSD17B10
SCHEMBL13067435 0.79 ALDH1A1 (0.40) CYP1A2ALDH1A1CYP3A4HSD17B10PTPN1
SCHEMBL10044606 0.78 CYP1A2 (0.44) CYP1A2TAAR1ALDH1A1CYP3A4HSD17B10
SCHEMBL10044442 0.78 CYP1A2 (0.44) CYP1A2TAAR1ALDH1A1CYP3A4HSD17B10
SCHEMBL4407605 0.76 PTPN1 (0.46) ALDH1A1CYP3A4PTPN1USP2MAPK1
SCHEMBL1047857 0.76 ALDH1A1 (0.46) CYP1A2ALDH1A1CYP3A4PTPN1CA12
SCHEMBL2096172 0.75 ALDH1A1 (0.50) CYP1A2ALDH1A1CYP3A4PTPN1APLNR
SCHEMBL19237538 0.75 TAAR1 (0.43) CYP1A2TAAR1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012052420-A1 METHOD FOR PREPARING SUBSTITUTED N-(3-AMINO-QUINOXALIN-2-YL)-SULFONAMIDES AND THEIR INTERMEDIATES N-(3-CHLORO-QUINOXALIN-2-YL)SULFONAMIDES MERCK SERONO S.A. GENEVA (CH) 2012-04-26 WO disclosed